Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionL2 Asset Management, LLC
Latest Disclosed Ownership66,161 shares
Latest Disclosed Value $ 9,220,838
L2 Asset Management, LLC reports 6.71% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - L2 Asset Management, LLC filed a 13F-HR form disclosing ownership of 66,161 shares of Gilead Sciences, Inc. (CH:GILD) valued at $9,220,838 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 70,920 shares of Gilead Sciences, Inc.. This represents a change in shares of -6.71% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 66,161 -4,759 -6.71 9,221 5.93 0.8771
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 70,920 10,200 16.80 8,705 29.16 1.1630
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 60,720 4,204 7.44 6,740 7.57 0.9753
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 56,516 28,592 102.39 6,266 100.29 1.0253
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 27,924 23,117 480.90 3,129 604.50 0.6391
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 4,807 -118 -2.40 444 7.77 0.0965
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 4,925 -6,171 -55.61 413 -45.86 0.1122
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 11,096 -9,500 -46.13 761 -49.54 0.2294
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 20,596 5,852 39.69 1,509 26.30 0.4953
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM 375558103 14,744 10,512 248.39 1,194 -30.86 0.4909
2023-11-08 2023-09-30 13F GILEAD SCIENCES COM 375558103 4,232 -54,287 -92.77 1,727 -62.10 0.8123
2023-08-11 2023-06-30 13F GILEAD SCIENCES COM 375558103 58,519 -166 -0.28 4,557 -6.41 2.2287
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 58,685 3,238 5.84 4,869 2.29 2.6821
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 55,447 344 0.62 4,760 40.04 2.9646
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 55,103 5,115 10.23 3,399 10.00 2.3390
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 49,988 15,970 46.95 3,090 52.82 2.2441
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 34,018 14,649 75.63 2,022 43.81 1.1625
2022-02-10 2021-12-31 13F GILEAD SCIENCES COM 375558103 19,369 16,216 514.30 1,406 539.09 0.9820
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 3,153 -6,296 -66.63 220 -66.21 0.5560
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 9,449 -8,964 -48.68 651 -45.29 0.6035
2021-05-17 2021-03-31 13F GILEAD SCIENCES COM 375558103 18,413 -2,435 -11.68 1,190 -2.06 1.2266
2021-02-12 2020-12-31 13F GILEAD SCIENCES COM 375558103 20,848 -6,293 -23.19 1,215 -29.15 0.8347
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 27,141 772 2.93 1,715 -15.48 1.3815
2020-08-13 2020-06-30 13F GILEAD SCIENCES COM 375558103 26,369 -8,362 -24.08 2,029 -21.84 1.8369
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 34,731 13,910 66.81 2,596 91.87 2.9142
2020-02-13 2019-12-31 13F GILEAD SCIENCES COM 375558103 20,821 20,821 1,353 1.1856
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.